The reduction in price target from $15 to $4 by Ascendiant Capital, despite maintaining a Buy rating, could lead to negative investor sentiment in the short term. This significant decrease in the price target may cause concerns about the company's future growth prospects or financial health, potentially leading to a decrease in stock price.